<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">36016376</PMID><DateCompleted><Year>2022</Year><Month>08</Month><Day>29</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>03</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1999-4915</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>8</Issue><PubDate><Year>2022</Year><Month>Aug</Month><Day>11</Day></PubDate></JournalIssue><Title>Viruses</Title><ISOAbbreviation>Viruses</ISOAbbreviation></Journal><ArticleTitle>Long-COVID Clinical Features and Risk Factors: A Retrospective Analysis of Patients from the STOP-COVID Registry of the PoLoCOV Study.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1755</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/v14081755</ELocationID><Abstract><AbstractText>Despite recovering from the acute phase of coronavirus disease (COVID-19), many patients report continuing symptoms that most commonly include fatigue, cough, neurologic problems, hair loss, headache, and musculoskeletal pain, a condition termed long-COVID syndrome. Neither its etiopathogenesis, nor its clinical presentation or risk factors are fully understood. Therefore, the purpose of this study was to retrospectively evaluate the most common symptoms of long-COVID among patients from the STOP COVID registry of the PoLoCOV study, and to search for risk factors for development of the syndrome. The registry includes patients who presented to the medical center for persistent clinical symptoms following severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. The analysis included data from initial presentation and at three-month follow-up. Of the 2218 patients, 1569 (70.7%) reported having at least one symptom classified as long-COVID syndrome three months after recovery from the initial SARS-CoV-2 infection. The most common symptoms included chronic fatigue (35.6%\), cough (23.0%), and a set of neurological symptoms referred to as brain fog (12.1%). Risk factors for developing long-COVID syndrome included female gender (odds ratio [OR]: 1.48, 95% confidence intervals [CI] [1.19-1.84]), severe COVID-19 (OR: 1.56, CI: 1.00-2.42), dyspnea (OR: 1.31, CI: 1.02-1.69), and chest pain (OR: 1.48, CI: 1.14-1.92). Long-COVID syndrome represents a significant clinical and social problem. The most common clinical manifestations are chronic fatigue, cough, and brain fog. Given the still-limited knowledge of long-COVID syndrome, further research and observation are needed to better understand the mechanisms and risk factors of the disease.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chudzik</LastName><ForeName>Micha&#x142;</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-8805-9688</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine and Geriatric Cardiology, Medical Centre for Postgraduate Education, 01-813 Warsaw, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Babicki</LastName><ForeName>Mateusz</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-7719-6959</Identifier><AffiliationInfo><Affiliation>Department of Family Medicine, Wroclaw Medical University, 51-141 Wroc&#x142;aw, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kapusta</LastName><ForeName>Joanna</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-5082-3641</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine and Cardiac Rehabilitation, Medical University of Lodz, 70-445 Lodz, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ka&#x142;uzi&#x144;ska-Ko&#x142;at</LastName><ForeName>&#x17b;aneta</ForeName><Initials>&#x17b;</Initials><Identifier Source="ORCID">0000-0002-2335-3293</Identifier><AffiliationInfo><Affiliation>Department of Experimental Surgery, Medical University of Lodz, 90-136 Lodz, Poland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Boruta Medical Center, 95-100 Zgierz, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ko&#x142;at</LastName><ForeName>Damian</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-1086-3796</Identifier><AffiliationInfo><Affiliation>Department of Experimental Surgery, Medical University of Lodz, 90-136 Lodz, Poland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Boruta Medical Center, 95-100 Zgierz, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jankowski</LastName><ForeName>Piotr</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0001-6223-8821</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine and Geriatric Cardiology, Medical Centre for Postgraduate Education, 01-813 Warsaw, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mastalerz-Migas</LastName><ForeName>Agnieszka</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-6600-2760</Identifier><AffiliationInfo><Affiliation>Department of Family Medicine, Wroclaw Medical University, 51-141 Wroc&#x142;aw, Poland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>08</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Viruses</MedlineTA><NlmUniqueID>101509722</NlmUniqueID><ISSNLinking>1999-4915</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003371" MajorTopicYN="N">Cough</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015673" MajorTopicYN="Y">Fatigue Syndrome, Chronic</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005222" MajorTopicYN="N">Mental Fatigue</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012042" MajorTopicYN="N">Registries</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">brain fog</Keyword><Keyword MajorTopicYN="N">fatigue</Keyword><Keyword MajorTopicYN="N">long-COVID</Keyword><Keyword MajorTopicYN="N">post-COVID-19 syndrome</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>7</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>8</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>8</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>8</Month><Day>26</Day><Hour>1</Hour><Minute>48</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>8</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>8</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>8</Month><Day>11</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36016376</ArticleId><ArticleId IdType="pmc">PMC9415629</ArticleId><ArticleId IdType="doi">10.3390/v14081755</ArticleId><ArticleId IdType="pii">v14081755</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>COVID Live&#x2014;Coronavirus Statistics&#x2014;Worldometer.  [(accessed on 11 June 2022)].  Available online:  https://www.worldometers.info/coronavirus/</Citation></Reference><Reference><Citation>SeyedAlinaghi S., Mirzapour P., Dadras O., Pashaei Z., Karimi A., MohsseniPour M., Soleymanzadeh M., Barzegary A., Afsahi A.M., Vahedi F., et al. Characterization of SARS-CoV-2 Different Variants and Related Morbidity and Mortality: A Systematic Review. Eur. J. Med. Res. 2021;26:51. doi: 10.1186/s40001-021-00524-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40001-021-00524-8</ArticleId><ArticleId IdType="pmc">PMC8185313</ArticleId><ArticleId IdType="pubmed">34103090</ArticleId></ArticleIdList></Reference><Reference><Citation>Flisiak R., Horban A., Jaroszewicz J., Kozielewicz D., Mastalerz-Migas A., Owczuk R., Parczewski M., Paw&#x142;owska M., Piekarska A., Simon K., et al. Management of SARS-CoV-2 Infection: Recommendations of the Polish Association of Epidemiologists and Infectiologists as of February 23, 2022. Pol. Arch. Intern. Med. 2022;132:16230. doi: 10.20452/pamw.16230.</Citation><ArticleIdList><ArticleId IdType="doi">10.20452/pamw.16230</ArticleId><ArticleId IdType="pubmed">35352546</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuter B.J., Offit P.A., Poland G.A. The Development of COVID-19 Vaccines in the United States: Why and How so Fast? Vaccine. 2021;39:2491&#x2013;2495. doi: 10.1016/j.vaccine.2021.03.077.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2021.03.077</ArticleId><ArticleId IdType="pmc">PMC7997594</ArticleId><ArticleId IdType="pubmed">33824043</ArticleId></ArticleIdList></Reference><Reference><Citation>Hammond J., Leister-Tebbe H., Gardner A., Abreu P., Bao W., Wisemandle W., Baniecki M., Hendrick V.M., Damle B., Sim&#xf3;n-Campos A., et al. Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with COVID-19. N. Engl. J. Med. 2022;386:1397&#x2013;1408. doi: 10.1056/NEJMoa2118542.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2118542</ArticleId><ArticleId IdType="pmc">PMC8908851</ArticleId><ArticleId IdType="pubmed">35172054</ArticleId></ArticleIdList></Reference><Reference><Citation>Jayk Bernal A., Gomes da Silva M.M., Musungaie D.B., Kovalchuk E., Gonzalez A., Delos Reyes V., Mart&#xed;n-Quir&#xf3;s A., Caraco Y., Williams-Diaz A., Brown M.L., et al. Molnupiravir for Oral Treatment of COVID-19 in Nonhospitalized Patients. N. Engl. J. Med. 2022;386:509&#x2013;520. doi: 10.1056/NEJMoa2116044.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2116044</ArticleId><ArticleId IdType="pmc">PMC8693688</ArticleId><ArticleId IdType="pubmed">34914868</ArticleId></ArticleIdList></Reference><Reference><Citation>Sigal A., Milo R., Jassat W. Estimating Disease Severity of Omicron and Delta SARS-CoV-2 Infections. Nat. Rev. Immunol. 2022;22:267&#x2013;269. doi: 10.1038/s41577-022-00720-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-022-00720-5</ArticleId><ArticleId IdType="pmc">PMC9002222</ArticleId><ArticleId IdType="pubmed">35414124</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M., Dercon Q., Luciano S., Geddes J.R., Husain M., Harrison P.J. Incidence, Co-Occurrence, and Evolution of Long-COVID Features: A 6-Month Retrospective Cohort Study of 273,618 Survivors of COVID-19. PLoS Med. 2021;18:e1003773. doi: 10.1371/journal.pmed.1003773.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1003773</ArticleId><ArticleId IdType="pmc">PMC8478214</ArticleId><ArticleId IdType="pubmed">34582441</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonelli M., Penfold R.S., Merino J., Sudre C.H., Molteni E., Berry S., Canas L.S., Graham M.S., Klaser K., Modat M., et al. Risk Factors and Disease Profile of Post-Vaccination SARS-CoV-2 Infection in UK Users of the COVID Symptom Study App: A Prospective, Community-Based, Nested, Case-Control Study. Lancet Infect. Dis. 2022;22:43&#x2013;55. doi: 10.1016/S1473-3099(21)00460-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00460-6</ArticleId><ArticleId IdType="pmc">PMC8409907</ArticleId><ArticleId IdType="pubmed">34480857</ArticleId></ArticleIdList></Reference><Reference><Citation>CDC Long COVID or Post-COVID Conditions.  [(accessed on 11 June 2022)]; Available online:  https://www.cdc.gov/coronavirus/2019-ncov/long-term-effects/index.html.</Citation></Reference><Reference><Citation>Yong S.J. Long COVID or Post-COVID-19 Syndrome: Putative Pathophysiology, Risk Factors, and Treatments. Infect. Dis. 2021;53:737&#x2013;754. doi: 10.1080/23744235.2021.1924397.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/23744235.2021.1924397</ArticleId><ArticleId IdType="pmc">PMC8146298</ArticleId><ArticleId IdType="pubmed">34024217</ArticleId></ArticleIdList></Reference><Reference><Citation>Cirulli E.T., Schiabor Barrett K.M., Riffle S., Bolze A., Neveux I., Dabe S., Grzymski J.J., Lu J.T., Washington N.L. Long-Term COVID-19 Symptoms in a Large Unselected Population. bioRxiv. 2020</Citation></Reference><Reference><Citation>Lu Y., Li X., Geng D., Mei N., Wu P.-Y., Huang C.-C., Jia T., Zhao Y., Wang D., Xiao A., et al. Cerebral Micro-Structural Changes in COVID-19 Patients&#x2014;An MRI-Based 3-Month Follow-up Study. EClinicalMedicine. 2020;25:100484. doi: 10.1016/j.eclinm.2020.100484.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2020.100484</ArticleId><ArticleId IdType="pmc">PMC7396952</ArticleId><ArticleId IdType="pubmed">32838240</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano J.B., Murthy S., Marshall J.C., Relan P., Diaz J.V. WHO Clinical Case Definition Working Group on Post-COVID-19 Condition A Clinical Case Definition of Post-COVID-19 Condition by a Delphi Consensus. Lancet Infect. Dis. 2022;22:e102&#x2013;e107. doi: 10.1016/S1473-3099(21)00703-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00703-9</ArticleId><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Overview&#x2014;COVID-19 Rapid Guideline: Managing the Long-Term Effects of COVID-19&#x2014;Guidance&#x2014;NICE.  [(accessed on 5 July 2022)].  Available online:  https://www.nice.org.uk/guidance/ng188.</Citation></Reference><Reference><Citation>Mehandru S., Merad M. Pathological Sequelae of Long-Haul COVID. Nat. Immunol. 2022;23:194&#x2013;202. doi: 10.1038/s41590-021-01104-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01104-y</ArticleId><ArticleId IdType="pmc">PMC9127978</ArticleId><ArticleId IdType="pubmed">35105985</ArticleId></ArticleIdList></Reference><Reference><Citation>Castanares-Zapatero D., Chalon P., Kohn L., Dauvrin M., Detollenaere J., Maertens de Noordhout C., Primus-de Jong C., Cleemput I., van den Heede K. Pathophysiology and Mechanism of Long COVID: A Comprehensive Review. Ann. Med. 2022;54:1473&#x2013;1487. doi: 10.1080/07853890.2022.2076901.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07853890.2022.2076901</ArticleId><ArticleId IdType="pmc">PMC9132392</ArticleId><ArticleId IdType="pubmed">35594336</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre C.H., Murray B., Varsavsky T., Graham M.S., Penfold R.S., Bowyer R.C., Pujol J.C., Klaser K., Antonelli M., Canas L.S., et al. Attributes and Predictors of Long COVID. Nat. Med. 2021;27:626&#x2013;631. doi: 10.1038/s41591-021-01292-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson E.J., Williams D.M., Walker A.J., Mitchell R.E., Niedzwiedz C.L., Yang T.C., Huggins C.F., Kwong A.S.F., Silverwood R.J., Gessa G.D., et al. Risk Factors for Long COVID: Analyses of 10 Longitudinal Studies and Electronic Health Records in the UK. bioRxiv. 2021</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C., Huang L., Wang Y., Li X., Ren L., Gu X., Kang L., Guo L., Liu M., Zhou X., et al. 6-Month Consequences of COVID-19 in Patients Discharged from Hospital: A Cohort Study. Lancet. 2021;397:220&#x2013;232. doi: 10.1016/S0140-6736(20)32656-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong A.W., Shah A.S., Johnston J.C., Carlsten C., Ryerson C.J. Patient-Reported Outcome Measures after COVID-19: A Prospective Cohort Study. Eur. Respir. J. 2020;56:2003276. doi: 10.1183/13993003.03276-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.03276-2020</ArticleId><ArticleId IdType="pmc">PMC7530908</ArticleId><ArticleId IdType="pubmed">33008936</ArticleId></ArticleIdList></Reference><Reference><Citation>Truffaut L., Demey L., Bruyneel A.V., Roman A., Alard S., de Vos N., Bruyneel M. Post-Discharge Critical COVID-19 Lung Function Related to Severity of Radiologic Lung Involvement at Admission. Respir. Res. 2021;22:29. doi: 10.1186/s12931-021-01625-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12931-021-01625-y</ArticleId><ArticleId IdType="pmc">PMC7819622</ArticleId><ArticleId IdType="pubmed">33478527</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-Las-Pe&#xf1;as C., Mart&#xed;n-Guerrero J.D., Pellicer-Valero &#xd3;.J., Navarro-Pardo E., G&#xf3;mez-Mayordomo V., Cuadrado M.L., Arias-Naval&#xf3;n J.A., Cigar&#xe1;n-M&#xe9;ndez M., Hern&#xe1;ndez-Barrera V., Arendt-Nielsen L. Female Sex Is a Risk Factor Associated with Long-Term Post-COVID Related-Symptoms but Not with COVID-19 Symptoms: The LONG-COVID-EXP-CM Multicenter Study. J. Clin. Med. 2022;11:413. doi: 10.3390/jcm11020413.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11020413</ArticleId><ArticleId IdType="pmc">PMC8778106</ArticleId><ArticleId IdType="pubmed">35054108</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobson K.B., Rao M., Bonilla H., Subramanian A., Hack I., Madrigal M., Singh U., Jagannathan P., Grant P. Patients with Uncomplicated Coronavirus Disease 2019 (COVID-19) Have Long-Term Persistent Symptoms and Functional Impairment Similar to Patients with Severe COVID-19: A Cautionary Tale during a Global Pandemic. Clin. Infect. Dis. 2021;73:e826&#x2013;e829. doi: 10.1093/cid/ciab103.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciab103</ArticleId><ArticleId IdType="pmc">PMC7929039</ArticleId><ArticleId IdType="pubmed">33624010</ArticleId></ArticleIdList></Reference><Reference><Citation>Wood E., Hall K.H., Tate W. Role of Mitochondria, Oxidative Stress and the Response to Antioxidants in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Possible Approach to SARS-CoV-2 &#x201c;long-Haulers? Chronic Dis. Transl. Med. 2021;7:14&#x2013;26. doi: 10.1016/j.cdtm.2020.11.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cdtm.2020.11.002</ArticleId><ArticleId IdType="pmc">PMC7680046</ArticleId><ArticleId IdType="pubmed">33251031</ArticleId></ArticleIdList></Reference><Reference><Citation>Tancheva L., Petralia M.C., Miteva S., Dragomanova S., Solak A., Kalfin R., Lazarova M., Yarkov D., Ciurleo R., Cavalli E., et al. Emerging Neurological and Psychobiological Aspects of COVID-19 Infection. Brain Sci. 2020;10:852. doi: 10.3390/brainsci10110852.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/brainsci10110852</ArticleId><ArticleId IdType="pmc">PMC7696269</ArticleId><ArticleId IdType="pubmed">33198412</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoubkhani D., Bermingham C., Pouwels K.B., Glickman M., Nafilyan V., Zaccardi F., Khunti K., Alwan N.A., Walker A.S. Trajectory of Long COVID Symptoms after COVID-19 Vaccination: Community Based Cohort Study. BMJ. 2022;377:e069676. doi: 10.1136/bmj-2021-069676.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2021-069676</ArticleId><ArticleId IdType="pmc">PMC9115603</ArticleId><ArticleId IdType="pubmed">35584816</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z., Bowe B., Xie Y. Long COVID after Breakthrough SARS-CoV-2 Infection. Nat. Med. 2022;28:1461&#x2013;1467. doi: 10.1038/s41591-022-01840-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01840-0</ArticleId><ArticleId IdType="pmc">PMC9307472</ArticleId><ArticleId IdType="pubmed">35614233</ArticleId></ArticleIdList></Reference><Reference><Citation>Siripanthong B., Nazarian S., Muser D., Deo R., Santangeli P., Khanji M.Y., Cooper L.T., Jr., Chahal C.A.A. Recognizing COVID-19-Related Myocarditis: The Possible Pathophysiology and Proposed Guideline for Diagnosis and Management. Heart Rhythm. 2020;17:1463&#x2013;1471. doi: 10.1016/j.hrthm.2020.05.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hrthm.2020.05.001</ArticleId><ArticleId IdType="pmc">PMC7199677</ArticleId><ArticleId IdType="pubmed">32387246</ArticleId></ArticleIdList></Reference><Reference><Citation>Asadi-Pooya A.A., Akbari A., Emami A., Lotfi M., Rostamihosseinkhani M., Nemati H., Barzegar Z., Kabiri M., Zeraatpisheh Z., Farjoud-Kouhanjani M., et al. Long COVID Syndrome-Associated Brain Fog. J. Med. Virol. 2022;94:979&#x2013;984. doi: 10.1002/jmv.27404.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27404</ArticleId><ArticleId IdType="pmc">PMC8662118</ArticleId><ArticleId IdType="pubmed">34672377</ArticleId></ArticleIdList></Reference><Reference><Citation>Gennaro D., Belati F., Tulone A., Diella O., Bavaro L., Bonica D.F., Genna R., Smith V., Trott L., Bruyere M. Long COVID: A Systematic Review and Meta-Analysis of 120,970 Patients. SSRN Electron. J. 2022 doi: 10.2139/ssrn.4099429.</Citation><ArticleIdList><ArticleId IdType="doi">10.2139/ssrn.4099429</ArticleId></ArticleIdList></Reference><Reference><Citation>Batabyal R., Freishtat N., Hill E., Rehman M., Freishtat R., Koutroulis I. Metabolic Dysfunction and Immunometabolism in COVID-19 Pathophysiology and Therapeutics. Int. J. Obes. 2021;45:1163&#x2013;1169. doi: 10.1038/s41366-021-00804-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41366-021-00804-7</ArticleId><ArticleId IdType="pmc">PMC7961323</ArticleId><ArticleId IdType="pubmed">33727631</ArticleId></ArticleIdList></Reference><Reference><Citation>Stefano G.B., Ptacek R., Ptackova H., Martin A., Kream R.M. Selective Neuronal Mitochondrial Targeting in SARS-CoV-2 Infection Affects Cognitive Processes to Induce &#x201c;Brain Fog&#x201d; and Results in Behavioral Changes That Favor Viral Survival. Med. Sci. Monit. 2021;27:e930886-1&#x2013;e930886-4. doi: 10.12659/MSM.930886.</Citation><ArticleIdList><ArticleId IdType="doi">10.12659/MSM.930886</ArticleId><ArticleId IdType="pmc">PMC7845145</ArticleId><ArticleId IdType="pubmed">33487628</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>